{
    "title": "Alexion bets on Portola's bleeding antidote with $1.41 bln deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8288675/Alexion-diversifies-treatment-portfolio-1-41-bln-Portola-deal.html",
    "date": "2020-05-05",
    "keywords": [
        "alexion",
        "officer",
        "andexxa",
        "deal",
        "population",
        "year",
        "drug",
        "hantson",
        "blood",
        "access",
        "covid19",
        "pandemic",
        "antidote",
        "portion",
        "target",
        "morning",
        "trading",
        "price",
        "share",
        "supply",
        "targeting",
        "lack",
        "familiarity",
        "potential",
        "goff",
        "xarelto",
        "bleeding",
        "fourthquarter",
        "uptake",
        "leadership",
        "addition",
        "string",
        "treatment",
        "pipepline",
        "hospital",
        "capability",
        "market",
        "ludwig",
        "street",
        "doctor",
        "trajectory",
        "show",
        "story",
        "term",
        "evolution",
        "analyst",
        "paul",
        "matteis",
        "achillion",
        "purchase",
        "syntimmune",
        "value",
        "drugmaker",
        "december",
        "push",
        "sale",
        "process",
        "reporting",
        "bengaluru",
        "editing",
        "dasgupta",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}